Try our Advanced Search for more refined results

Analysis

Allergan Deal May Set Stage For More Tribal Patent Pacts

By Andrew Westney ( September 14, 2017, 9:28 PM EDT) -- A recent deal struck to shield Allergan PLC's patents for dry eye medication Restasis behind a New York tribe's sovereign immunity is drawing fire from generic-drug makers and others who claim the move is an abuse of tribal sovereignty, but attorneys say the pact should prove legal and may pave the way for similar agreements....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!